Skip to main content
Log in

Impediments to DNA Testing and Cascade Screening for Hypertrophic Cardiomyopathy and Long QT syndrome: A Qualitative Study of Patient Experiences

  • Original Research
  • Published:
Journal of Genetic Counseling

Abstract

This paper reports data from a qualitative study of patient experiences of DNA testing and cascade screening for hypertrophic cardiomyopathy and long QT syndrome, cardiac conditions that place sufferers at risk of sudden death. The paper particularly focuses on potential impediments to testing and screening. Semi-structured interviews were undertaken with a purposive sample of 27 people in the UK who had undergone testing. In the context of the uncertainties that can characterize experiences of these disorders, the majority of participants in this sample embraced testing and screening as a way of providing health information for themselves or their relatives (particularly children). There was nevertheless evidence of ambivalence about the value and impact of the DNA test information which could influence participants’ dispositions toward testing, and play into dilemmas about family communication. Other concerns arose in relation to communicating about these disorders, decisions to involve elderly relatives and pressures relating to family responsibility. The evidence of ambivalence provides insight into why some people may be resistant to testing, screening and sharing information. The findings about communication processes indicate potential areas of concern for the cascading process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Alcalai, R., Seidman, J. G., & Seidman, C. E. (2008). Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. Journal of Cardiovascular Electrophysiolology, 19, 104–110.

    Google Scholar 

  • Andersen, J., Øyen, N., Bjorvatn, C., & Gjengedal, E. (2008). Living with long QT syndrome: a qualitative study of coping with increased risk of sudden cardiac death. Journal of Genetic Counseling, 17, 489–498.

    Article  PubMed  Google Scholar 

  • Bazeley, P., & Richards, L. (2000). The NVivo qualitative project book. London: Sage.

    Google Scholar 

  • Charron, P., Héron, D., Gargiulo, M., Richard, P., Dubourg, O., Desnos, M., et al. (2002). Genetic testing and genetic counselling in hypertrophic cardiomyopathy: the French experience. Journal of Medical Genetics, 39, 741–746.

    Article  CAS  PubMed  Google Scholar 

  • Chiang, C. E. (2004). Congenital and acquired long QT syndrome. Current concepts and management. Cardiology in Review, 12, 222–234.

    Article  PubMed  Google Scholar 

  • Christiaans, I., Birnie, E., Bonsel, G. J., Wilde, A. A., & van Langen, I. M. (2008). Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy. European Journal of Human Genetics, 16, 1201–1207.

    Article  PubMed  Google Scholar 

  • Christiaans, I., van Langen, I. M., Birnie, E., Bonsel, G. J., Wilde, A. A., & Smets, E. M. (2009a). Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. American Journal of Medical Genetics, 149A, 602–612.

    Article  PubMed  Google Scholar 

  • Christiaans, I., van Langen, I. M., Birnie, E., Bonsel, G. J., Wilde, A. A., & Smets, E. M. (2009b). Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients’ perspective. American Journal of Medical Genetics, 149A, 1444–1451.

    Article  PubMed  Google Scholar 

  • Clarke, A., Richards, M., Kerzin-Storrar, L., Halliday, J., Young, M. A., Simpson, S. A., et al. (2005). Genetic professionals’ reports of nondisclosure of genetic risk information within families. European Journal of Human Genetics, 13, 556–562.

    Article  PubMed  Google Scholar 

  • Cox, S., O’Donoghue, A., McKenna, W. J., & Steptoe, A. (1997). Health related quality of life and psychological wellbeing in patients with Hypertrophic Cardiomyopathy. Heart, 78, 182–187.

    CAS  PubMed  Google Scholar 

  • Crotti, L., Celano, G., Dagradi, F., & Schwartz, P. J. (2008). Congenital long QT syndrome. Orphanet Journal of Rare Diseases, 3, 18.

    Article  PubMed  Google Scholar 

  • De Wert, G. (2005). Cascade screening: whose information is it anyway? European Journal of Human Genetics, 13, 397–398.

    Article  PubMed  Google Scholar 

  • Dey, I. (1993). Qualitative data analysis: A user-friendly guide for social scientists. London: Routledge.

    Book  Google Scholar 

  • Farnsworth, M. M., Fosyth, D., Haglund, C., & Ackerman, M. J. (2006). When I go in to wake them...I wonder: parental perceptions about congenital long QT syndrome. Journal of the American Academy of Nurse Practitioners, 18, 284–290.

    Article  PubMed  Google Scholar 

  • Gaff, C. L., Clarke, A. J., Atkinson, P., Sivell, S., Elwyn, G., Iredale, R., et al. (2007). Process and outcome in communication of genetic information within families: a systematic review. European Journal of Human Genetics, 15, 999–1011.

    Article  PubMed  Google Scholar 

  • Gomm, R. (2004). Social research methodology. A critical introduction. Basingstoke: Palgrave MacMillan.

    Google Scholar 

  • Hintsa, T., Keltikangas-Jarvinen, L., Puttonen, S., Ravaja, N., Toivonen, L., Kontula, K., et al. (2009). Depressive symptoms in the congenital long QT syndrome. Annals of Medicine, 23, 1–6.

    Article  Google Scholar 

  • Hedley, P. L., Jørgensen, P., Schlamowitz, S., Wangari, R., Moolman-Smook, J., Brink, P. A., et al. (2009). The genetic basis of long QT and short QT syndromes: a mutation update. Human Mutation, 30(11), 1486–1511.

    Article  CAS  PubMed  Google Scholar 

  • Hendriks, K. S. W. H., Grosfeld, F. J. M., van Tintelen, J. P., van Langen, I. M., Wilde, A. A. M., van den Bout, J., et al. (2005). Can parents adjust to the idea that their child is at risk for a sudden death? Psychological impact of risk for QT syndrome. American Journal of Medical Genetics, 138(2), 107–112.

    Google Scholar 

  • Ingles, J., Doolan, A., Chiu, C., Seidman, J. G., Seidman, C., & Semsarian, C. (2005). Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. Journal of Medical Genetics, 42, e59.

    Article  CAS  PubMed  Google Scholar 

  • Ingles, J., Lind, J. M., Phongsavan, P., & Semsarian, C. (2008). Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy. Genetics in Medicine, 10, 117–120.

    Article  PubMed  Google Scholar 

  • Keenan, K. F., Simpson, S. A., Wilson, B. J., Van Teijlingen, E. R., McKee, L., Haites, N., et al. (2005). ‘It’s their blood not mine’: who’s responsible for (not) telling relatives about genetic risk? Health Risk & Society, 7, 209–226.

    Article  Google Scholar 

  • Keren, A., Syrris, P., & McKenna, W. J. (2008). Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nature Clinical Practice: Cardiovascular Medicine, 5, 158–168.

    Article  CAS  PubMed  Google Scholar 

  • Lind, J. M., Chiu, C., & Semsarian, C. (2006). Genetic basis of hypertrophic cardiomyopathy. Expert Review of Cardiovascular Therapy, 4, 927–934.

    Article  CAS  PubMed  Google Scholar 

  • Maron, B. (2002). Hypertrophic Cardiomyopathy, a systematic review. Journal of American Medical Association, 287, 1308–1320.

    Article  Google Scholar 

  • Maron, B. J., Chaitman, B. R., Ackerman, M. J., Bayés de Luna, A., Corrado, D., Crosson, J. E., et al. (2004). Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation, 109, 2807–2816.

    Article  PubMed  Google Scholar 

  • Marteau, T., & Mitchie, S. (1995). A positive screening test for an untreatable condition provides psychological relief from uncertainty. British Medical Journal, 311, 58–59.

    CAS  PubMed  Google Scholar 

  • Michels, M., Hoedemaekers, Y. M., Kofflard, M. J., Frohn-Mulder, I., Dooijes, D., Majoor-Krakauer, D., et al. (2007). Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience. Netherlands Heart Journal, 15, 184–190.

    Article  CAS  PubMed  Google Scholar 

  • Morgan, J. F., O’Donoghue, A. C., McKenna, W. J., & Schmidt, M. M. (2008). Psychiatric disorders in hypertrophic cardiomyopathy. General Hospital Psychiatry, 30, 49–54.

    Article  PubMed  Google Scholar 

  • Ritchie, J., Lewis, J., & Elam, G. (2003). Designing and selecting samples. In J. Ritchie & J. Lewis (Eds.), Qualitative research practice: A guide for social science students and researchers (pp. 77–108). London: Sage.

    Google Scholar 

  • Sola, C. L., & Bostwick, J. M. (2005). Implantable cardioverter-defibrillators, induced anxiety, and quality of life. Mayo Clinic Proceedings, 80, 232–237.

    Article  PubMed  Google Scholar 

  • Spencer, L., Ritchie, J., & O’Connor, W. (2003). Analysis: practices, principles and processes. In J. Ritchie & J. Lewis (Eds.), Qualitative research practice: A guide for social science students and researchers (pp. 199–218). London: Sage.

    Google Scholar 

  • van Langen, I. M., Hofman, N., Tan, H. L., & Wilde, A. A. (2004). Family and population strategies for screening and counselling of inherited cardiac arrhythmias. Annals of Medicine, 36(Suppl 1), 116–124.

    Article  PubMed  Google Scholar 

  • Vincent, G. M. (1998). The molecular genetics of the long QT syndrome: genes causing fainting and sudden death. Annual Review of Medicine, 49, 263–274.

    Article  CAS  PubMed  Google Scholar 

  • Wilson, B. J., Forrest, K., van Teijlingen, E. R., McKee, L., Haites, N., Matthews, E., et al. (2004). Family communication about genetic risk: the little that is known. Community Genetics, 7, 15–24.

    Article  PubMed  Google Scholar 

  • Yu, B., French, J. A., Jeremy, R. W., French, P., McTaggart, D. R., Nicholson, M. R., et al. (1997). Counselling issues in familial Hypertrophic Cardiomyopathy. Journal of Medical Genetics, 35, 183–188.

    Article  Google Scholar 

Download references

Acknowledgements

This work was funded by the Oxford Genetics Knowledge Park, with support from colleagues in Ethox (M. Parker), GKP management (J. Taylor, S. Dopson), Cardiovascular Medicine (H. Watkins), Genetics (E. Blair) and the Oxford Molecular Genetics Laboratory (A. Seller, K. Thomson). Thanks are also due to the steering group for their comments on the original proposal, practitioners around the UK for distributing information packs, Anne Jolly (SADS UK) and Stephanie Cruickshank (CMA UK) for their guidance, and in particular to Cassie Fraser-Jones (Cardiac Genetics Counselor) for her comments throughout, and to the interviewees who kindly agreed to participate.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew Smart.

Appendix: Interview Guide

Appendix: Interview Guide

  1. Theme A.

    Experiences of the Condition and Treatment

    • Personal and family history of the disorder

    • What has happened during medical care?

  2. Theme B.

    DNA Testing

    • Why offered the DNA test?

    • What were the results?

    • Key reasons for having the test?

    • Any difficulties in making the choice?

    • Effects of DNA test on how they think about the condition.

  3. Theme C.

    Family Communication

    • Were they the first person to have a DNA test? Who else has had a test?

    • Did they contact other family members about the test? Who and why?

    • Were there family members they didn’t contact? Who and why?

    • Difficulties in the process of communicating with relatives.

    • Amount of (and preferred) support/ advice/ information from the medical team.

  4. Theme D.

    Benefits and Drawbacks

    • The positive and negative outcomes of DNA testing for them and their family.

    • Has participation in DNA testing left any lingering concerns or outstanding problems?

  5. Theme E.

    Information Provision

    • What information was given about the implications of the results of a DNA test?

    • Was this given at appropriate times, and were there opportunities to discuss issues, concerns or problems?

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smart, A. Impediments to DNA Testing and Cascade Screening for Hypertrophic Cardiomyopathy and Long QT syndrome: A Qualitative Study of Patient Experiences. J Genet Counsel 19, 630–639 (2010). https://doi.org/10.1007/s10897-010-9314-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10897-010-9314-0

Keywords

Navigation